Skip to content
Disclosery

Trustees of Columbia University in the City of New York

Follow

13F filer, CIK 1420995, NEW YORK, NY

Trustees of Columbia University in the City of New York reported $829,751,243 across 4 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000904454-26-000100

Period
2025-12-31
Reported value
$830M
Holdings
4
Top 10 weight
100%
New
2
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SPYadded+231,301$158M
IWBnew+7,775$2.9M
FIGnew+11,514$430K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SRZNexited-47,930-$618K
TNYAexited-291,828-$473K
QTTBexited-133,903-$265K
RAPTexited-9,172-$237K
VORexited-4,595-$224K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0000904454-26-000100, largest first. % of portfolio is the value over $829,751,243, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SPYSTATE STR SPDR S&P 500 ETF TQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,071,799 shares; 2025Q1: 1,109,343 shares; 2025Q2: 1,112,613 shares; 2025Q3: 980,596 shares; 2025Q4: 1,211,897 shares 1,211,897$826M99.6%+231,301Timeline
IWBISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,775 shares 7,775$2.9M0.35%newTimeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 11,514 shares 11,514$430K0.05%newTimeline
SRZNWSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 33,333 shares; 2025Q1: 33,333 shares; 2025Q2: 33,333 shares; 2025Q3: 33,333 shares; 2025Q4: 33,333 shares 33,333$667<0.01%0Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SRZNSURROZEN INC47,930$618Kshares
TNYATENAYA THERAPEUTICS INC291,828$473Kshares
QTTBQ32 BIO INC133,903$265Kshares
RAPTRAPT THERAPEUTICS INC9,172$237Kshares
VORVOR BIOPHARMA INC4,595$224Kshares
XLOXilio Therapeutics Inc.249,635$210Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000904454-26-000100 base2026-02-13acceptance time not in the bulk data set